Baker Bros. Advisors »

Compass Pathways shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Compass Pathways (CMPS) shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Compass Pathways

Tip: Access up to 7 years of quarterly data

All positions including Compass Pathways held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Pathways by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $13M 2.3M 5.53

More positions owned by Baker Bros. Advisors

Incyte Corporation (INCY)
BeOne Medicines Sponsored Ads (ONC)
Insmed Incorporated Com Par $.01 (INSM)
Madrigal Pharmaceuticals (MDGL)
ACADIA Pharmaceuticals (ACAD)
Revolution Medicines (RVMD)
Celcuity (CELC)
Kodiak Sciences (KOD)
Kymera Therapeutics (KYMR)
Summit Therapeutics (SMMT)
Praxis Precision Medicines I (PRAX)
Rhythm Pharmaceuticals (RYTM)
Alkermes SHS (ALKS)
Grail (GRAL)
Edgewise Therapeutics (EWTX)

View all positions for Baker Bros. Advisors

Top funds holding Compass Pathways

Deep Track Capital
Rtw Investments
Tang Capital Management
BIT Capital GmbH
ARK Investment Management
Millennium Management
GMT Capital Corp
Two Sigma Investments
DAFNA Capital Management
Baker Bros. Advisors
Eagle Health Investments
UBS Group
Susquehanna International
Leucadia National Corporation
Aisling Capital Management

View all funds holding Compass Pathways